Header Logo

Connection

WEN-JEN HWU to New Zealand

Back to Details
This is a "connection" page, showing publications WEN-JEN HWU has written about New Zealand.
WEN-JEN HWU
Connection Strength
0.038
New Zealand
  1. Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial. Lancet Oncol. 2017 09; 18(9):1202-1210.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.